HealthTech Innovation Days (HTID®), organized by the HealthTech For Care endowment fund, on October 24th and 25th, 2023, is offering an auspicious place to exchange to innovation and science sector actors, in order to lead solutions faster to their patients and position them in the center of innovation. The 5th edition will takes place in Paris, at the HealthTech Space, and also virtually, on October 27th only.
HTID® combines meetings between companies, investors, industrial and pharmaceutical companies, and more generally all industry stakeholders, including patients and patient associations. Moreover, conferences on major topics of general interest are hosted by international experts and are accessible to all on HTFC endowment fund website after the event.
Companies that want to contribute to HTID® are welcomed to apply. A jury will reunite every two weeks in order to examine the interest of the applications, according to the purpose of the endowment fund, which is to quickly ensure the best benefit for patients.
The following selection criteria allow us to address healthtech companies that have reached a stage of development that allows their solutions to benefit patients:
• Biotechs, developping treatment currently in clinical phase
• Medtechs, developping a technology close to market or on the market
• Innovative service companies, developping products and innovative services in high demand by health sector actors
• Digital Health, proposing an approved of developped product benefiting from partnerships with hospitals, pharmas or industrial companies
Registration link : https://www.surveymonkey.com/r/htid5-application
“For the fifth consecutive year, we are proud to organize HealthTech Innovation Days, under the high patronage of Mr Emmanuel MACRON, President of the French Republic. This not-to-be-missed event European conference welcomes all sector actors in order to answer tomorrow’s challenges, and thus help patients access faster to latest innovations.” Maryvonne Hiance, HealthTech For Care funds dotation’s President.
The initiative is supported by many European players, together with our association: Asebio, BioAlps, BIO Deutschland, BioWin, CEBR, flanders.bio, Medvia, HollandBIO, IREFI, Swiss Biotech, Technion.